Discover B2B companies, suppliers, and manufacturers related to this keyword category
Innovation in Immunotherapy to Treat Inflammation and Infection
BC Cancer provides a province wide, population-based cancer control program. Privacy & moderation: phsa.ca/privacy
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Pioneering RNA cell therapy for autoimmune disease
We are a global allergy solutions company, pioneering in allergy research for more than 100 years.
Dedicated to science - Committed to your health
Developing Innovative Cell Therapies Against Cancer
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
The cell and gene therapy development and manufacturing organization within New York Blood Center Enterprises
The leading Spatial Biology Software Platform for Precision Medicine.
This page is no longer active. Please follow us at Emmes. Our new website is https://www.emmes.com/emmes-europe.
The First Cell-Centered Computational Model of Human Disease
Innovative pharmaceutical company revolutionizing bladder cancer treatment
Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.
Media specialists providing cell culture solutions for industrial, clinical and research applications for over 50 years.
The nation's first not-for-profit biomedical research organization
We are a San Francisco-based Venture Studio reimagining drug discovery to develop transformative immunotherapies
Enabling precision medicine to improve life for people with allergies
An Australian-first bench-to-bedside medical research institute, translating medical discoveries into improved health.
Permanent Self-Vaccination Against Cancer
Our passion drives us to provide new health solutions advancing human life
Providing high purity reagents and improved peptide binding services to drive your next HLA discovery.
We support drug discovery through translational research across oncology and immuno-oncology.
Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy
Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges.
A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line)
Immunotherapy Ventures
Expertise in Cell and Gene Therapies, based out of Montreal QC and Toronto ON.
We are developing advanced therapies for cancer patients with critical unmet needs
Open cells to new possibilities: Accelerating cell therapy processes from discovery through manufacturing with Flowfect®
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.
Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer
Transforming imaging data into actionable predictions
Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers
Bringing Effective New Treatments And Options To Patients Who Need Them
Harnessing more of the immune system for better cancer outcomes
The science driven BioPark at the heart of Europe.
MAIA Biotechnology is a targeted therapy, immuno-oncology company focused on development of first-in-class drugs
Harnessing the power of a semi-synthetic organism with an expanded genetic alphabet to develop protein therapeutics
Presenting live and digital music events that raise awareness and funding for cancer treatment, research, and programs.
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
We are the largest and best-equipped cancer treatment centre in West Africa. Radiotherapy | Brachytherapy | Chemotherapy
Targeted delivery of nanoparticles for in vivo CAR T therapy
Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers
Destroying tumors by targeting cancer cell fitness.
We combine multi-omics data, AI, computational biology, and MIDD for the next era of diagnosis and patient treatment.
GYNECOLOGY,SURGERY,ONCOLOGY, IVF, PRENATAL CARE, FETAL MEDICINE, DELIVERY AND POSTNATAL CARE, NEONATOLOGY AND PEDIATRICS
Davidoff center, Beilinson hospital
Overcoming Resistance In Cancer
A biotech company developing novel dermaceutical products for oncology patients undergoing clinical treatment
Engineering the next-generation of T cell receptor therapies against cancer
Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.
An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.
"Harnessing the power of the immune system to improve health of companion animals”
Interventional Immuno-Oncology
A unique full-service CDMO, setting new standards in Cell & Gene Therapy
Consortium dedicated to partnership-based research on lymphomas
Engineering cures for patients with autoimmune & inflammatory diseases.
A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies.
People affected by prostate cancer need breakthroughs. Research is the only way we can turn this hope to reality.
CDMO expert specialized in gene delivery
Powerful & precise T cell therapy that attacks solid tumors while sparing normal cells.
is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.
Funding research. Convening partners. Advancing solutions for food allergies.
Reshaping the future of immunotherapies
Eliminating the obstacles in your path to optimal wellness.
Global vision to make molecular medicine affordable and accessible
Cutting-edge peer-reviewed research and analysis on genome editing and CRISPR biology.
Activating cures so countless more individuals like Emily can survive and thrive.
Committed to Accelerating Medicines of the Future
DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.
DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.